Cargando…

Early prediction of therapy response in patients with acute myeloid leukemia by nucleosomal DNA fragments

BACKGROUND: Elevated levels of nucleosomal DNA fragments can be detected in plasma and sera of patients with malignant diseases. METHODS: We investigated the course of nucleosomal DNA, thymidine kinase, lactate dehydrogenase and leukocytes in sera of 25 patients with acute myeloid leukemia during th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mueller, Susanne, Holdenrieder, Stefan, Stieber, Petra, Haferlach, Torsten, Schalhorn, Andreas, Braess, Jan, Nagel, Dorothea, Seidel, Dietrich
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1555596/ https://www.ncbi.nlm.nih.gov/pubmed/16734907 http://dx.doi.org/10.1186/1471-2407-6-143

Ejemplares similares

Relevance of circulating nucleosomes and oncological biomarkers for predicting response to transarterial chemoembolization therapy in liver cancer patients
por: Kohles, Nikolaus, et al.
Publicado: (2011)

Predictive and prognostic value of circulating nucleosomes and serum biomarkers in patients with metastasized colorectal cancer undergoing Selective Internal Radiation Therapy
por: Fahmueller, Yvonne Nadine, et al.
Publicado: (2012)

Acute myeloid leukemia
por: Haferlach, Torsten
Publicado: (2019)

Advancing leukemia diagnostics: Role of Next Generation Sequencing (NGS) in acute myeloid leukemia
por: Haferlach, Torsten
Publicado: (2020)

Cytokeratin 19-fragments (CYFRA 21-1) as a novel serum biomarker for response and survival in patients with advanced pancreatic cancer
por: Boeck, S, et al.
Publicado: (2013)

Outcome of elderly patients with acute promyelocytic leukemia: results of the German Acute Myeloid Leukemia Cooperative Group
por: Lengfelder, Eva, et al.
Publicado: (2012)

Minimal Residual Disease Diagnostics and Chimerism in the Post-Transplant Period in Acute Myeloid Leukemia
por: Bacher, Ulrike, et al.
Publicado: (2011)

Impact of emerging ACA on survival in chronic myeloid leukemia (CML)
por: Hehlmann, Rüdiger, et al.
Publicado: (2022)

Comprehensive genetic diagnosis of acute myeloid leukemia by next-generation sequencing
por: Mack, Elisabeth K.M., et al.
Publicado: (2019)

Serial profiling of cell-free DNA and nucleosome histone modifications in cell cultures
por: Ungerer, Vida, et al.
Publicado: (2021)

Circulating cell-free methylated DNA and lactate dehydrogenase release in colorectal cancer
por: Philipp, Alexander B, et al.
Publicado: (2014)

Nucleosome repositioning during differentiation of a human myeloid leukemia cell line
por: Teif, Vladimir B., et al.
Publicado: (2017)

A Bioinformatics View on Acute Myeloid Leukemia Surface Molecules by Combined Bayesian and ABC Analysis
por: Thrun, Michael C., et al.
Publicado: (2022)

Cell-Free DNA Fragmentation Patterns in a Cancer Cell Line
por: Ungerer, Vida, et al.
Publicado: (2022)

The power and potential of integrated diagnostics in acute myeloid leukaemia
por: Haferlach, Torsten, et al.
Publicado: (2019)

A 19-year-old patient with atypical chronic myeloid leukemia
por: Ernst, Philipp, et al.
Publicado: (2020)

Expression of CEBPA is reduced in RUNX1-mutated acute myeloid leukemia
por: Grossmann, V, et al.
Publicado: (2012)

Histone Methylation Marks on Circulating Nucleosomes as Novel Blood-Based Biomarker in Colorectal Cancer
por: Gezer, Ugur, et al.
Publicado: (2015)

Circulating Nucleosomes as Potential Markers to Monitor COVID-19 Disease Progression
por: Cavalier, Etienne, et al.
Publicado: (2021)

Nucleosome repositioning in chronic lymphocytic leukemia
por: Piroeva, Kristan V., et al.
Publicado: (2023)

Erufosine, a novel alkylphosphocholine, in acute myeloid leukemia: single activity and combination with other antileukemic drugs
por: Fiegl, Michael, et al.
Publicado: (2007)

Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia
por: Rothenberg-Thurley, Maja, et al.
Publicado: (2018)

SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia
por: van der Werf, Inge, et al.
Publicado: (2021)

Chronic myeloid leukemia
por: Sauβele, Susanne
Publicado: (2018)

Comprehensive study on ERG gene expression in normal karyotype acute myeloid leukemia: ERG expression is of limited prognostic value, whereas the accumulation of adverse prognostic markers stepwise worsens the prognosis
por: Weber, S, et al.
Publicado: (2016)

A new way of measuring apoptosis by absolute quantitation of inter-nucleosomally fragmented genomic DNA
por: Hooker, David J., et al.
Publicado: (2012)

Validation and refinement of the revised 2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemia
por: Herold, Tobias, et al.
Publicado: (2020)

Detection of ABL1 kinase domain mutations in therapy-naïve BCR-ABL1-positive acute lymphoblastic leukemia
por: Baer, Constance, et al.
Publicado: (2021)

Nonlinear approximation theory
por: Braess, Dietrich
Publicado: (1986)

Finite elements: theory, fast solvers, and applications in solid mechanics
por: Braess, Dietrich
Publicado: (2007)

Validation and refinement of the 2022 European LeukemiaNet genetic risk stratification of acute myeloid leukemia
por: Rausch, Christian, et al.
Publicado: (2023)

DNA Damage and DNA Damage Response in Chronic Myeloid Leukemia
por: Popp, Henning D., et al.
Publicado: (2020)

Clinical application of whole transcriptome sequencing for the classification of patients with acute lymphoblastic leukemia
por: Walter, Wencke, et al.
Publicado: (2021)

BAALC expression: a suitable marker for prognostic risk stratification and detection of residual disease in cytogenetically normal acute myeloid leukemia
por: Weber, S, et al.
Publicado: (2014)

Scalable Prediction of Acute Myeloid Leukemia Using High-Dimensional Machine Learning and Blood Transcriptomics
por: Warnat-Herresthal, Stefanie, et al.
Publicado: (2019)

Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV
por: Michel, Christian, et al.
Publicado: (2019)

Loss of PALB2 predicts poor prognosis in acute myeloid leukemia and suggests novel therapeutic strategies targeting the DNA repair pathway
por: Padella, Antonella, et al.
Publicado: (2021)

High-mobility group box 1 protein, receptor for advanced glycation end products and nucleosomes increases after marathon
por: Schoenfeld, Julia, et al.
Publicado: (2023)

Efficacy of azacitidine is independent of molecular and clinical characteristics - an analysis of 128 patients with myelodysplastic syndromes or acute myeloid leukemia and a review of the literature
por: Kuendgen, Andrea, et al.
Publicado: (2018)

Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia—a phase 3 study
por: Braess, Jan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jcublbb7vfhvkd53nj3c71j89k